Evidence map›Paper›PMID 31002636›Full record

ArticlePreventing chronic disease2019

The Public Health Leadership and Implementation Academy for Noncommunicable Diseases.

Karla I Galaviz, K M Venkat Narayan, Olivia C Manders, Gabriela Torres-Mejía, Shifalika Goenka, Deborah A McFarland, K Srinath Reddy, Rafael Lozano, Laura Magaña Valladares, Dorairaj Prabhakaran and 1 more

Abstract read
In one paragraph

Article in Preventing chronic disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Karla I GalavizRollins School of Public Health, Emory University, Atlanta, Georgia.
K M Venkat NarayanRollins School of Public Health, Emory University, Atlanta, Georgia.
Olivia C MandersRollins School of Public Health, Emory University, Atlanta, Georgia.
Gabriela Torres-MejíaNational Institute of Public Health, Cuernavaca, Morelos, Mexico.
Shifalika GoenkaPublic Health Foundation of India, New Delhi, India.
Deborah A McFarlandRollins School of Public Health, Emory University, Atlanta, Georgia.
K Srinath ReddyPublic Health Foundation of India, New Delhi, India.
Rafael LozanoInstitute for Health Metrics and Evaluation, Department of Global Health, University of Washington, Seattle, Washington.
Laura Magaña ValladaresNational Institute of Public Health, Cuernavaca, Morelos, Mexico.
Dorairaj PrabhakaranPublic Health Foundation of India, New Delhi, India.
Mohammed K AliRollins School of Public Health, Emory University, 1518 Clifton Rd, Rm 7041 CNR Building, Atlanta, GA. Email: mkali@emory.edu.

Funding

Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
Health systems & implementation sciences institute for NCDs in SoAsia & LatinAmD43TW009135 · FIC · EMORY UNIVERSITY · PI LOZANO, RAFAEL, NARAYAN, KABAYAM M VENKAT · 2012 to 2016
$1.1M
FIC NIH HHS D43 TW009135NIDDK NIH HHS P30 DK111024
6 · The paper itself

Abstract

PURPOSE AND

objectivesLow- and middle-income countries (LMICs) have a large burden of noncommunicable diseases and confront leadership capacity challenges and gaps in implementation of proven interventions. To address these issues, we designed the Public Health Leadership and Implementation Academy (PH-LEADER) for noncommunicable diseases. The objective of this program evaluation was to assess the quality and effectiveness of PH-LEADER. INTERVENTION APPROACH: PH-LEADER was directed at midcareer public health professionals, researchers, and government public health workers from LMICs who were involved in prevention and control of noncommunicable diseases. The 1-year program focused on building implementation research and leadership capacity to address noncommunicable diseases and included 3 complementary components: a 2-month online preparation period, a 2-week summer course in the United States, and a 9-month, in-country, mentored project. EVALUATION

methodsFour trainee groups participated from 2013 through 2016. We collected demographic information on all trainees and monitored project and program outputs. Among the 2015 and 2016 trainees, we assessed program satisfaction and pre-post program changes in leadership practices and the perceived competence of trainees for performing implementation research.

resultsNinety professionals (mean age 38.8 years; 57% male) from 12 countries were trained over 4 years. Of these trainees, 50% were from India and 29% from Mexico. Trainees developed 53 projects and 9 publications. Among 2015 and 2016 trainees who completed evaluation surveys (n = 46 of 55), we saw pre-post training improvements in the frequency with which they acted as role models (Cohen's d = 0.62, P <.001), inspired a shared vision (d = 0.43, P =.005), challenged current processes (d = 0.60, P <.001), enabled others to act (d = 0.51, P =.001), and encouraged others by recognizing or celebrating their contributions and accomplishments (d = 0.49, P =.002). Through short on-site evaluation forms (scale of 1-10), trainees rated summer course sessions as useful (mean, 7.5; SD = 0.2), with very good content (mean, 8.5; SD = 0.6) and delivered by very good professors (mean, 8.6; SD = 0.6), though they highlighted areas for improvement. IMPLICATIONS FOR PUBLIC HEALTH: The PH-LEADER program is a promising strategy to build implementation research and leadership capacity to address noncommunicable diseases in LMICs.

Indexed as

Disease ManagementLeadershipAdultDelivery of Health CareFemaleHealth PersonnelHumansMaleMiddle AgedNoncommunicable DiseasesPublic Health

Identifiers

PMID31002636
PMCPMC6513477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.